These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 650223)

  • 61. Lanthanum binding to murine neuroblastoma cells.
    El-Fakahany E; Lopez JR; Richelson E
    J Neurochem; 1983 Jun; 40(6):1687-91. PubMed ID: 6854326
    [No Abstract]   [Full Text] [Related]  

  • 62. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elevation of cyclic AMP in C-1300 murine neuroblastoma by adenosine and related compounds and the antagonism of this response by methylxanthines.
    Green RD; Stanberry LR
    Biochem Pharmacol; 1977 Jan; 26(1):37-43. PubMed ID: 188425
    [No Abstract]   [Full Text] [Related]  

  • 64. Intermediate (10 nm)-filaments in undifferentiated cells of mouse neuroblastoma clones.
    Bertolini L; Amini M; Vigneti E; Bosman C; Revoltella R
    Differentiation; 1977 Oct; 8(3):175-81. PubMed ID: 563354
    [No Abstract]   [Full Text] [Related]  

  • 65. Wilsede Meeting on Modern Trends in Human Leukaemia VI. June 17-21, 1984. Differentiation: Paradigm and paradox at Wilsede.
    Francis GE
    Leuk Res; 1985; 9(8):951-4. PubMed ID: 4046633
    [No Abstract]   [Full Text] [Related]  

  • 66. In vitro protein synthesis activity of poly(A) RNA from neuroblastoma cells.
    Cuppelo A; Dierich A; Mandel P; Wintzerith M
    Neurochem Res; 1980 Mar; 5(3):271-9. PubMed ID: 6154901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 5-bromodeoxyuridine-induced differentiation of a neuroblastoma.
    Schubert D; Jacob F
    Proc Natl Acad Sci U S A; 1970 Sep; 67(1):247-54. PubMed ID: 5272316
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.
    Silagi S
    In Vitro; 1971; 7(2):105-14. PubMed ID: 5170776
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparative effects on growth and tumorigenicity of mouse melanoma cells by thymidine and its analogs, 5-ethyl- and 5-bromodeoxyuridine.
    Silagi S; Balint RF; Gauri KK
    Cancer Res; 1977 Sep; 37(9):3367-73. PubMed ID: 884681
    [No Abstract]   [Full Text] [Related]  

  • 70. Bromodeoxyuridine effects on the RNA sequence complexity and phenotype in a neuroblastoma clone.
    Schrier BK; Zubairi MY; Letendre CH; Grouse LD
    Differentiation; 1978 Nov; 12(1):23-30. PubMed ID: 729957
    [No Abstract]   [Full Text] [Related]  

  • 71. DNA of bromodeoxyuridine-treated neuroblastoma cells.
    Wintzerith M; Dierich A; Ciesielski-Treska J; Mandel P
    J Neurochem; 1978 Apr; 30(4):813-20. PubMed ID: 650223
    [No Abstract]   [Full Text] [Related]  

  • 72. [Radiation sensitization of brain neoplasms by haloid analogs of pyrimidine bases].
    Lokshina AM; Pelevina II
    Med Radiol (Mosk); 1973 Mar; 18(3):70-7. PubMed ID: 4267617
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.